Status: retired, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2755409017 | Ophthlamic form physostigmine (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2765839016 | Ophthlamic form eserine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 2774288017 | Ophthlamic form physostigmine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 2789121014 | Ophthalmic form physostigmine (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2793006013 | Ophthalmic form physostigmine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 2793007016 | Ophthalmic form eserine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3487703017 | Product containing physostigmine in ophthalmic dosage form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3496308018 | Physostigmine in ophthalmic dosage form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3496309014 | Product containing physostigmine in ophthalmic dosage form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Physostigmine in ophthalmic dosage form | Is a | Drugs used in the eye | false | Inferred relationship | Some | ||
| Physostigmine in ophthalmic dosage form | Is a | Physostigmine-containing product | false | Inferred relationship | Some | ||
| Physostigmine in ophthalmic dosage form | Has active ingredient | Physostigmine | false | Inferred relationship | Some | ||
| Physostigmine in ophthalmic dosage form | Has manufactured dose form | Ocular dose form | false | Inferred relationship | Some | ||
| Physostigmine in ophthalmic dosage form | Is a | Product manufactured as ocular dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eserine sulphate 1.0% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine- and pilocarpine-containing product | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine 0.25% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine 0.5% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine+pilocarpine 0.5%+4% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine+pilocarpine 0.25%+4% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some | |
| Physostigmine+pilocarpine 0.25%+2% eye drops | Is a | False | Physostigmine in ophthalmic dosage form | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set
FHIR